Haemonetics Corporation (HAE)

Total asset turnover

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Revenue (ttm) US$ in thousands 2,596,175 2,424,725 2,393,776 2,373,078 2,323,237 1,114,154 1,068,622 1,011,034 987,485 954,649 935,251 904,840 862,112 882,733 901,332 944,412 989,857 1,000,660 989,046 978,061
Total assets US$ in thousands 2,195,590 2,200,430 2,011,280 1,962,260 1,934,820 1,878,070 1,865,110 1,820,530 1,859,730 1,831,380 1,801,500 1,794,190 1,819,920 1,318,070 1,418,170 1,433,170 1,267,110 1,237,750 1,190,540 1,259,610
Total asset turnover 1.18 1.10 1.19 1.21 1.20 0.59 0.57 0.56 0.53 0.52 0.52 0.50 0.47 0.67 0.64 0.66 0.78 0.81 0.83 0.78

March 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,596,175K ÷ $2,195,590K
= 1.18

Haemonetics Corporation's total asset turnover has shown a fluctuating trend over the past few quarters. The company's total asset turnover ratio has generally been increasing since the end of 2020. This indicates that the company has been more effective in generating sales revenue from its total assets during this period. The highest total asset turnover ratio was observed in the most recent quarter at 1.18, suggesting that the company is efficiently utilizing its assets to generate revenue.

However, there have been periods, such as in the second half of 2022, where the total asset turnover ratio was relatively low, indicating a less efficient use of assets to generate sales. Overall, the increasing trend in total asset turnover is a positive sign for Haemonetics Corporation as it implies better asset utilization and potential for improved financial performance.


Peer comparison

Mar 31, 2024